FXR
Farnesoid X Receptor (FXR) is a nuclear receptor that plays a key role in the regulation of bile acid homeostasis, lipid metabolism, and glucose regulation. FXR is a potential therapeutic target for treating liver diseases, metabolic disorders, and cardiovascular diseases. FXR inhibitors can modulate these pathways, offering insights into disease mechanisms and therapeutic strategies. At CymitQuimica, we provide a range of FXR inhibitors to support your research in hepatology, metabolism, and drug development.
Found 62 products of "FXR"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Chenodeoxycholic Acid 24-Acyl-β-D-Glucuronide
CAS:Chenodeoxycholic acid 24-acyl-β-D-glucuronide (CDCA-24G), a metabolite of CDCA, is synthesized from CDCA via the action of the UDP-glucuronosyltransferase (UG UT) isoform UGT1A3.Formula:C30H48O10Color and Shape:SolidMolecular weight:568.7Chenodeoxycholic Acid 3-Glucuronide
CAS:Chenodeoxycholic acid 3-glucuronide (CDCA-3G), a metabolite of Chenodeoxycholic acid (CDCA), is synthesized in human liver microsomes.Formula:C30H48O10Color and Shape:SolidMolecular weight:568.7GSK-8062
CAS:GSK-8062 is an agonist of farnesoid X receptor (FXR).Formula:C30H23Cl2NO4Purity:98%Color and Shape:SolidMolecular weight:532.41Omesdafexor
CAS:Omesdafexor is an FXR agonist that can be used to study diseases caused by liver disease or metabolic inflammation.Formula:C34H43N3O3Color and Shape:SolidMolecular weight:541.72Lecufexor
CAS:Lecufexor is an agonist of the farnesoid X receptor (FXR).Formula:C32H21Cl3N2O5Color and Shape:SolidMolecular weight:619.88BAR-2227
CAS:BAR-2227 (compound 3a) functions as an FXR agonist and a LIFR inhibitor. It is utilized in the study of liver fibrosis and inflammation.Formula:C24H17Cl2NO4Color and Shape:SolidMolecular weight:454.30BMS-986339
CAS:BMS-986339: oral, potent FXR agonist; binds to His298/ASN287; for PBC, PSC, NASH, anti-fibrosis research.Formula:C35H41F4N3O4Color and Shape:SolidMolecular weight:643.71Danifexor
CAS:Danifexor is an agonist of the farnesoid X receptor (Farnesoid X receptor).Formula:C29H20Cl2N2O5Color and Shape:SolidMolecular weight:547.386FXR agonist 12
CAS:FXR agonist12 (Compound C7) is an orally active FXR agonist. It downregulates bile acid synthesis-related genes and upregulates bile acid transport-related genes in HepG2 cells. FXR agonist12 alleviates ANIT-induced cholestasis and reduces liver damage and fibrosis in a mouse model of NASH.
Formula:C26H44O3Color and Shape:SolidMolecular weight:404.626FXR agonist 9
CAS:FXR agonist9 (compound 26) is a selective, orally active partial agonist of FXR with an EC50 of 0.09 µM (maximum efficacy of 75.13%). It ameliorates the pathological features of fatty liver disease in mice induced by HFD and CCl4-related metabolic dysfunction.Formula:C28H30N2O5Color and Shape:SolidMolecular weight:474.55NR1H4 activator 1
CAS:NR1H4 activator 1 is a potent and selective agonist of Famesoid X Receptor (FXR).Formula:C34H53NO7SPurity:98%Color and Shape:SolidMolecular weight:619.85FXR/CES2 modulator 1
CAS:Compound LE-77, known as FXR/CES2 modulator 1, functions as a dual regulator that activates FXR and inhibits CES2. It effectively mitigates the intestinal toxicity of irinotecan.Formula:C27H21Cl2NO5Color and Shape:SolidMolecular weight:510.36
